CD4 and laryngotracheoesophageal cleft: In the case of EZH2-reactive CD4 T-cell responses, clone SK31 (EZH295-109-reactive, DR1-restricted) recognized several EZH2+/DR1+ LC tumors (LU65, EBC1 and LC-2/ad, Figure 8A).